Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Unknown 5Terminated 3Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 3Recurrence 1Neoplasm Recurrence, Local 1Liver Neoplasms 1Liver Cirrhosis 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 49Radiotherapy 47Docetaxel 42Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Imatinib Mesylate 14Drug Therapy 14Irinotecan 13Filgrastim 13Zoledronic Acid 12Trastuzumab 12Radiosurgery 12Erlotinib Hydrochloride 12Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Ethiodized Oil × Clear all
NCT02762266 2024-03-12

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

Stanford University

Phase 3 Terminated
13 enrolled 12 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT01387932 2021-11-30

HiQuality

Merit Medical Systems, Inc.

Phase 3 Terminated
235 enrolled 11 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT00470340 2011-05-05

GEMOXIAL

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated
263 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms, Neoplasm Recurrence, Local, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡